The Report
Deep dives into company funding, growth strategies, and market insights from the world's most innovative businesses
12,014 reports and counting
Seres Therapeutics Raises $113M in Series E
Seres Therapeutics, a Biotech company based in 200 Sidney Street, Cambridge, MA 02139, has raised $113M in Series E at a $450M valuation led by Flagship Pioneering, Polaris Partners, Fidelity, Nestle Health Science, Takeda Ventures.
Vor Biopharma Raises $110M in Series C
Vor Biopharma, a Biotech company based in 200 Sidney Street, Cambridge, MA 02139, has raised $110M in Series C at a $700M valuation led by 5AM Ventures, Fidelity, SR One, Novartis Venture Fund, Cormorant Asset Management.
State Street Corporation raises $80B Public at $85B valuation
State Street Corporation raises $80B in Public at $85B valuation. Financial services and bank holding company...
State Street Corporation Raises $80B in Public
State Street Corporation, a Asset Management company based in 1 Congress Street, Boston, MA 02114, has raised $80B in Public at a $85B valuation led by Public.
Block Street Raises $11.5M in Seed
Block Street, a FinTech company based in San Francisco, CA, has raised $11.5M in Seed at a $55M valuation led by Hack VC, Generative Ventures.
Where is Cloud Computing Company 200's Headquarters? Main Office Location
Cloud Computing Company 200's global headquarters is located at 200 Tech Drive, Boston, MA 90199. The office serves as the central hub for the company's Cloud Computing operations.
Seres Therapeutics raises $113M Series E at $450M valuation
Seres Therapeutics raises $113M in Series E at $450M valuation. Microbiome therapeutic platform...
Vor Biopharma raises $110M Series C at $700M valuation
Vor Biopharma raises $110M in Series C at $700M valuation. Engineering hematopoietic stem cells...
Block Street raises $11.5M Seed at $55M valuation
Block Street raises $11.5M in Seed at $55M valuation. Blockchain and traditional finance infrastructure platform...
Showing 9 reports • Page 1 • Category: all
Stay ahead of the market
Get weekly insights delivered to your inbox. No spam, just intelligence.